These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 19836350

  • 1. Traf2 interacts with Smad4 and regulates BMP signaling pathway in MC3T3-E1 osteoblasts.
    Shimada K, Ikeda K, Ito K.
    Biochem Biophys Res Commun; 2009 Dec 18; 390(3):775-9. PubMed ID: 19836350
    [Abstract] [Full Text] [Related]

  • 2. Ubc9 promotes the stability of Smad4 and the nuclear accumulation of Smad1 in osteoblast-like Saos-2 cells.
    Shimada K, Suzuki N, Ono Y, Tanaka K, Maeno M, Ito K.
    Bone; 2008 May 18; 42(5):886-93. PubMed ID: 18321803
    [Abstract] [Full Text] [Related]

  • 3. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
    Yamashita M, Otsuka F, Mukai T, Otani H, Inagaki K, Miyoshi T, Goto J, Yamamura M, Makino H.
    J Endocrinol; 2008 Mar 18; 196(3):601-13. PubMed ID: 18310456
    [Abstract] [Full Text] [Related]

  • 4. TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells.
    Ando T, Ichikawa J, Wako M, Hatsushika K, Watanabe Y, Sakuma M, Tasaka K, Ogawa H, Hamada Y, Yagita H, Nakao A.
    Arthritis Res Ther; 2006 Mar 18; 8(5):R146. PubMed ID: 16945157
    [Abstract] [Full Text] [Related]

  • 5. Bone morphogenetic protein activities are enhanced by 3',5'-cyclic adenosine monophosphate through suppression of Smad6 expression in osteoprogenitor cells.
    Sugama R, Koike T, Imai Y, Nomura-Furuwatari C, Takaoka K.
    Bone; 2006 Feb 18; 38(2):206-14. PubMed ID: 16203197
    [Abstract] [Full Text] [Related]

  • 6. Runx2 regulates FGF2-induced Bmp2 expression during cranial bone development.
    Choi KY, Kim HJ, Lee MH, Kwon TG, Nah HD, Furuichi T, Komori T, Nam SH, Kim YJ, Kim HJ, Ryoo HM.
    Dev Dyn; 2005 May 18; 233(1):115-21. PubMed ID: 15765505
    [Abstract] [Full Text] [Related]

  • 7. TNF-alpha inhibits BMP-induced osteoblast differentiation through activating SAPK/JNK signaling.
    Mukai T, Otsuka F, Otani H, Yamashita M, Takasugi K, Inagaki K, Yamamura M, Makino H.
    Biochem Biophys Res Commun; 2007 May 18; 356(4):1004-10. PubMed ID: 17397798
    [Abstract] [Full Text] [Related]

  • 8. Parathyroid hormone enhances bone morphogenetic protein activity by increasing intracellular 3', 5'-cyclic adenosine monophosphate accumulation in osteoblastic MC3T3-E1 cells.
    Nakao Y, Koike T, Ohta Y, Manaka T, Imai Y, Takaoka K.
    Bone; 2009 May 18; 44(5):872-7. PubMed ID: 19442611
    [Abstract] [Full Text] [Related]

  • 9. Twisted gastrulation and chordin inhibit differentiation and mineralization in MC3T3-E1 osteoblast-like cells.
    Petryk A, Shimmi O, Jia X, Carlson AE, Tervonen L, Jarcho MP, O'connor MB, Gopalakrishnan R.
    Bone; 2005 Apr 18; 36(4):617-26. PubMed ID: 15780974
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Galectin-9 induces osteoblast differentiation through the CD44/Smad signaling pathway.
    Tanikawa R, Tanikawa T, Hirashima M, Yamauchi A, Tanaka Y.
    Biochem Biophys Res Commun; 2010 Apr 02; 394(2):317-22. PubMed ID: 20206131
    [Abstract] [Full Text] [Related]

  • 13. The effects of BIG-3 on osteoblast differentiation are not dependent upon endogenously produced BMPs.
    Gori F, Demay MB.
    Exp Cell Res; 2005 Mar 10; 304(1):287-92. PubMed ID: 15707593
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Glypican-3 modulates inhibitory Bmp2-Smad signaling to control renal development in vivo.
    Hartwig S, Hu MC, Cella C, Piscione T, Filmus J, Rosenblum ND.
    Mech Dev; 2005 Jul 10; 122(7-8):928-38. PubMed ID: 15925496
    [Abstract] [Full Text] [Related]

  • 16. SMAD expression in the testis: an insight into BMP regulation of spermatogenesis.
    Itman C, Loveland KL.
    Dev Dyn; 2008 Jan 10; 237(1):97-111. PubMed ID: 18069690
    [Abstract] [Full Text] [Related]

  • 17. A small nuclear acidic protein (MTI-II, Zn2+-binding protein, parathymosin) attenuates TNF-α inhibition of BMP-induced osteogenesis by enhancing accessibility of the Smad4-NF-κB p65 complex to Smad binding element.
    Hirata-Tsuchiya S, Suzuki S, Okamoto K, Saito N, Yuan H, Yamada S, Jimi E, Shiba H, Kitamura C.
    Mol Cell Biochem; 2020 Jun 10; 469(1-2):133-142. PubMed ID: 32304006
    [Abstract] [Full Text] [Related]

  • 18. Regulation of neuropeptide Y Y1 receptor expression by bone morphogenetic protein 2 in C2C12 myoblasts.
    Kurebayashi N, Sato M, Fujisawa T, Fukushima K, Tamura M.
    Biochem Biophys Res Commun; 2013 Oct 04; 439(4):506-10. PubMed ID: 24025680
    [Abstract] [Full Text] [Related]

  • 19. Bone morphogenetic proteins and Smad expression in ovine tendon-bone healing.
    Yu Y, Bliss JP, Bruce WJ, Walsh WR.
    Arthroscopy; 2007 Feb 04; 23(2):205-10. PubMed ID: 17276229
    [Abstract] [Full Text] [Related]

  • 20. Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor.
    Kanzaki S, Takahashi T, Kanno T, Ariyoshi W, Shinmyouzu K, Tujisawa T, Nishihara T.
    J Cell Physiol; 2008 Sep 04; 216(3):844-50. PubMed ID: 18449905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.